Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population

Human Immunology

Volumn 73, Issue 1, 2012, Pages 101-106

  Yang, Bin ^a   Chen, Jie ^a   Li, Yi ^a   Zhang, Junlong ^a   Li, Dongdong ^a   Huang, Zhuochun ^a   Cai, Bei ^a   Li, Lixin ^a   Shi, Yunying ^a   Ying, Binwu ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

C reactive protein (CRP); Erythrocyte sedimentation rate (ESR); Inflammatory cytokine; MicroRNA; Rheumatoid arthritis (RA); SNPs

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; MICRORNA; MICRORNA 146A; MICRORNA 499; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84355161620     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.10.005     Document Type: Article

References (34)

1. Smolen J.S., Aletaha D., Koeller M., Weisman M.H., Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007, 370:1861-1874.
2. Lipsky P.E., van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., Kalden J.R., et al. Infliximab and methotrexate in the treatment of rheumatoid arthritismor: Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000, 343:1594-1602.
3. Lee U.J., Choung S.R., Prakash K.V., Lee E.J., Lee M.Y., Kim Y.J., et al. Dual knockdown of p65 and p50 subunits of NF-kappaB by siRNA inhibits the induction of inflammatory cytokines and significantly enhance apoptosis in human primary synoviocytes treated with tumor necrosis factor-alpha. Mol Biol Rep 2008, 35:291-298.
4. Fabbri M., Croce C.M., Calin G.A. MicroRNAs. Cancer J 2008, 14:1-6.
5. Lodish H.F., Zhou B., Liu G., Chen C.Z. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008, 8:120-130.
6. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
7. Zamore P.D., Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309:1519-1524.
8. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K., et al. R-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008, 10:1-10.
9. Hillyer P., Larché M.J., Bowman E.P., McClanahan T.K., de Waal Malefyt R., Schewitz L.P., et al. Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis. Rheumatology (Oxford) 2009, 48:1581-1589.
10. Ying B., Shi Y., Pan X., Song X., Huang Z., Niu Q., et al. Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis. Mol Biol Rep 2011, 38:379-385.
11. Yuan F.L., Hu W., Lu W.G., Li X., Li J.P., Xu R.S., et al. Targeting interleukin-21 in rheumatoid arthritis. Mol Biol Rep 2011, 38:1717-1721.
12. Huang C.H., Cong L., Xie J., Qiao B., Lo S.H., Zheng T. Rheumatoid arthritis-associated gene-gene interaction network for rheumatoid arthritis candidate genes. BMC Proc 2009, 15(3 suppl 7):S75.
13. Lin S.C., Kuo C.C., Chan C.H. Association of a BTLA gene polymorphism with the risk of rheumatoid arthritis. J Biomed Sci 2006, 13:853-860.
14. van Gaalen F.A., van Aken J., Huizinga T.W.J., Schreuder G.M.Th., Breedveld F.C., Zanelli E., et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004, 50:2113-2121.
15. Senkpiehl I., Marget M., Wedler M., Jenisch S., Georgi J., Kabelitz D., et al. HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis. Int Arch Allergy Immunol 2005, 137:315-318.
16. Thabet M.M., Wesoly J., Slagboom P.E., Toes R.E., Huizinga T.W. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007, 66:803-806.
17. Raychaudhuri S., Thomson B.P., Remmers E.F., Eyre S., Hinks A.Candace Guiducci, et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009, 41:1313-1318.
18. Orozco G., Hinks A., Eyre S., Ke X., Gibbons L.J., Bowes J., et al. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum Mol Genet 2009, 18:2693-2699.
19. Gandjbakhch F., Fajardy I., Ferré B., Dubucquoi S., Flipo R.M., Roger N., et al. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population. J Rheumatol 2009, 36:881-886.
20. Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 2004, 208:1-33.
21. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801.
22. Jazdzewski K., Liyanarachchi S., Swierniak M., Pachucki J., Ringel M.D., Jarzab B., et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA 2009, 106:1502-1505.
23. Xu B., Feng N.H., Li P.C., Tao J., Wu D., Zhang Z.D., et al. A functional polymorphism in pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 2009, 9:1-6.
24. Xu T., Zhu Y., Wei Q.K., Yuan Y., Zhou F., Ge Y.Y., et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008, 29:2126-2131.
25. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
26. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
27. Hu Z., Chen J., Tian T., Zhou X., Gu H., Xu L., et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008, 118:2600-2608.
28. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
29. Rhodes B., Merriman M.E., Merriman A., Harrison A., Nissen M.J., Smith M., et al. A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Medicine 2010, 7:e1000341.
30. Crawford D.C., Sanders C.L., Qin X., Smith J.D., Shephard C., et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006, 114:2458-2465.
31. Kathiresan S., Larson M.G., Vasan R.S., Guo C.Y., Gona P., et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006, 113:1415-1423.
32. Nakasa T., Miyaki S., Okubo A., Hashimoto M., Nishida K., Ochi M., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008, 58:1284-1292.
33. Lu L.-F., Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009, 127:291-298.
34. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.